Genetic Technologies Ltd (GTG.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 03-2012 | |
| Cash Flows From Operating Activities | |
| Operating Cash Flow | $N/A |
| Cash Flows From Investing Activities | |
| Other Investing Activity | -29 |
| Investing Cash Flow | $-29 |
| Cash Flows From Financing Activities | |
| Change In Short Term Borrowing | 845 |
| Debt Repayment | -13 |
| Other Financing Activity | 8 |
| Financing Cash Flow | $840 |
| Exchange Rate Effect | 29 |
| Beginning Cash Position | 12,581 |
| End Cash Position | 11,450 |
| Net Cash Flow | $-1,160 |
| Free Cash Flow | |